Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 34.15
+0.65 (1.94%)
At close: Feb 11, 2026
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.47 billion as of February 11, 2026. Its market cap has increased by 6.36% in one year.
Market Cap
1.47B
Enterprise Value
975.14M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.15
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has decreased from 1.48B to 1.47B, a decrease of -0.80%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.44B | 4.69% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.89B |
| Genomics BioSci & Tech. | 1.78B |
| NeoCore Technology | 1.54B |
| Abnova (Taiwan) | 1.54B |
| GenMont Biotech Incorporation | 1.53B |
| Enimmune | 1.43B |
| Meribank Biotech | 1.30B |
| GeneReach Biotechnology | 1.20B |